Singapore maintains biomed strength with 60+ plants despite closures

Sector drew $4.4b in 2025 investments, supporting jobs and continued manufacturing expansion.

Deputy Prime Minister and Minister for Trade and Industry Gan Kim Yong said Singapore continues to be a major global biomedical sciences manufacturing centre, even as some companies adjust their global production footprint.

In a written parliamentary reply on 7 May, he said Singapore hosts more than 60 biomedical sciences manufacturing plants, including eight of the world’s top 10 biopharmaceutical companies.

He added that the sector attracted $4.4b in investments in 2025, according to the Economic Development Board, with projects expected to create about 1,775 jobs over the next five years.

One example cited was AstraZeneca’s $1.90b (USD1.5b) antibody drug conjugate facility, which is its first end-to-end plant of that type globally.

Gan said recent plant closures reflect individual companies’ commercial decisions and not a weakening of Singapore’s competitiveness.

He also said the government will continue to support manufacturers in upgrading capabilities, including through artificial intelligence and robotics adoption.

Against this backdrop, one termination is BioNTech closing its Singapore and German sites as part of a global restructuring affecting about 1,860 staff, according to a Reuters report.

The company said production of its COVID-19 vaccine will be transferred to partner Pfizer, with the Singapore facility expected to cease operations by early 2027.

A NOTE FROM SINGAPORE BUSINESS REVIEW

If you've been wondering whether SBR could work for your company — yes, probably.

A lot of the companies we partner with started as readers. They'd been following our coverage for a while, saw their own customers and competitors in it, and eventually asked the obvious question: could we do something with you? The answer is usually yes. The shape of it depends on what you're trying to do.

The options are broader than most people assume — thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. Some partners use one channel; most use a mix. We figure out the right combination by starting with your brief, not with our rate card.

So if the question has been on your mind, here's the easy way to ask it.

We'll tell you honestly whether we can help, and how. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia